Your browser doesn't support javascript.
loading
[Clinical Significance of EBV-DNA Copy Number in EBV Positive Lymphoma Patients].
Qiu, Li-Hua; Li, Yue-Yang; Zheng, Ya-Xin; Yuan, Tian; Ding, Sa; Qian, Zheng-Zi; Li, Lan-Fang; Feng, Yu-Mei; Zhang, Hui-Lai; Tian, Chen.
Afiliación
  • Qiu LH; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Li YY; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Zheng YX; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Yuan T; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Ding S; Department of Oncology, Hotan District People's Hospital of Xinjiang, Hotan 848000, Xinjiang Uygur Autonomous Region, China.
  • Qian ZZ; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Li LF; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Feng YM; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Zhang HL; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Tian C; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China,Department of Oncology, Hotan District People's Hospital of Xinjiang, Hotan 848000, Xinjiang Uygur
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 29(6): 1785-1789, 2021 Dec.
Article en Zh | MEDLINE | ID: mdl-34893111
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Herpesvirus Humano 4 / Linfoma Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Herpesvirus Humano 4 / Linfoma Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: China